Dongsung Pharmaceutical

002210 · KOSPI · ₩002210 · 동성제약

₩1,196▼ ₩27 (2.21%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩87B₩88B₩89B₩93B₩84B
Cost of sales₩50B₩50B₩47B₩51B₩51B
Gross profit₩37B₩39B₩41B₩42B₩34B
Operating income−₩10B−₩5.7B₩596M−₩3.1B−₩5.3B
Net income−₩26B−₩15B−₩2.1B−₩2.1B−₩4.3B
Net income to shareholders−₩26B−₩15B−₩2.1B−₩2.1B−₩4.3B

Balance sheet

20252024202320222021
Total assets₩168B₩141B₩115B₩108B₩105B
Current assets₩89B₩57B₩61B₩54B₩50B
Cash and equivalents₩3.9B₩3.1B₩6.4B₩4.1B₩3.1B
Total liabilities₩145B₩97B₩75B₩65B₩58B
Current liabilities₩130B₩77B₩45B₩48B₩38B
Borrowings₩64B₩52B₩43B₩45B₩29B
Total equity₩23B₩44B₩40B₩43B₩46B
Shareholders' equity₩23B₩44B₩40B₩43B₩46B

Cash flow

20252024202320222021
Cash from operations−₩13B−₩6.7B−₩4.3B−₩3.9B−₩2.8B
Free cash flow−₩13B−₩6.7B−₩4.3B−₩3.9B−₩2.8B

Consolidated where available. Amounts in won.

Also known as: Dongsung Pharmaceutical / 동성제약 / 002210 / KRX:002210

Source: KRX statistical information